Erectile Dysfunction.

  title={Erectile Dysfunction.},
  author={Karl Thomas Rew and Joel J. Heidelbaugh},
  journal={American family physician},
  volume={94 10},
Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It is common, affecting at least 12 million U.S. men. The five-question International Index of Erectile Function allows rapid clinical assessment of ED. The condition can be caused by vascular, neurologic, psychological, and hormonal factors. Common conditions related to ED include diabetes mellitus, hypertension, hyperlipidemia, obesity, testosterone deficiency, and… 
The blue pill (sildenafil) and its descendants: an overview
The current medical guidelines recommend PDE-5 inhibitors as the firstline therapy for most men with ED, irrespective of the cause and severity of the disease.
Neutrophil-Lymphocyte Ratio Could Be a Marker for Erectile Dysfunction.
It was found that the neutrophil-lymphocyte ratio was higher in patient group than the control group and it might be helpful in diagnosing erectile dysfunction.
Relación entre varicocele, disfunción sexual y niveles séricos de testosterona
Findings suggest varicocele might be involved in the occurrence of sexual dysfunction due to decreased levels of testosterone.
Direct-to-Consumer Advertising on Public Health Outcomes: Can Viagra Advertising Make More Babies?
It is demonstrated that increased ED drug television advertising leads to a higher birth rate, suggesting that beyond the customer purchase decision, advertising can have important public health outcomes, with resulting implications for policy formulation and managerial decision-making.


Management of erectile dysfunction.
Lifestyle changes, modifying drug therapy that may cause ED, and pharmacotherapy with phosphodiesterase type 5 inhibitors are the most effective oral drugs for treatment of ED, including ED associated with diabetes mellitus, spinal cord injury, and antidepressants.
Diagnostic evaluation of erectile dysfunction.
  • T. Miller
  • Medicine
    American family physician
  • 2000
Erectile dysfunction, the persistent inability to attain or maintain penile erection sufficient for sexual intercourse, affects millions of men to various degrees and can have a negative impact on self-esteem, quality of life and interpersonal relationships.
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.
The updated version of 2009 European Association of Urology guidelines on ED and PE are presented to present, summarising the present information onED and PE.
Erectile Dysfunction in the Elderly: An Old Widespread Issue with Novel Treatment Perspectives
The aim of the present review was to examine the main aspects of erectile dysfunction going through epidemiology and pathophysiology and revise most of ED in elderly disabled men and in those affected with psychiatric disorders.
Pharmacotherapeutic management of erectile dysfunction
The search for highly specific, simple, convenient and clinically effective impotence treatments or prophylactics continues.
Evaluation of young men with organic erectile dysfunction
A thorough work-up should be employed for any man with complaints of sexual dysfunction and specific testing should be directed by clinical clues noted during the preliminary evaluation to assist in diagnosis and help guide therapy.
Psychogenic erectile dysfunction. Classification and management.
  • R. Rosen
  • Medicine
    The Urologic clinics of North America
  • 2001
A new definition and classification of psychogenic erectile dysfunction has been proposed based on recent clinical and research findings, and special situations have been identified in which combining psychosocial interventions with medical therapy is recommended.
Erectile dysfunction and mortality.
Findings demonstrate that ED is significantly associated with increased all-cause mortality, primarily through its association with CVD mortality.
Newer pharmacologic alternatives for erectile dysfunction.
With the introduction of effective pharmacologic therapies for erectile dysfunction, more men are seeking treatment, and consideration should be given to existing medical illnesses and medications, partner satisfaction, comfort with the method of administration and the side effect profile.
Intraurethral Alprostadil for Erectile Dysfunction
Data from key clinical studies of intraurethral alprostadil show that it has a fast onset of effect and a good safety profile, with no occurrences of priapism, fibrosis, or the typical systemic effects observed with oral ED pharmacological treatments.